Why the study?
Does a novel pathophysiological classification predict 90-day MACEs in first-time STEMI patients?
Does a novel pathophysiological classification predict 90-day MACEs in first-time STEMI patients?
A novel pathophysiological classification using CMR and echocardiography effectively stratifies post-STEMI patients and independently predicts 90-day major adverse cardiovascular events.
Answers are grounded in this paper and cite their sources.
May support post-STEMI risk stratification; hypothesis-generating and requires prospective validation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
He et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: